ArticleInternational journal of clinical oncology2021

Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance.

Makoto Tahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.